Skip to main content

Table 3 List of nineteen abnormal karyotype results (continued)

From: Is routine karyotyping required in prenatal samples with a molecular or metabolic referral?

Case no Karyotype STC Karyotype LTC ≥ 36 years Karyotype
AF
Follow-up testing Type Pregnancy
follow-up and clinical outcome
DNA analysis or metabolic testing
Aberration in LTC, not in STC         
11 46, XX[4] 47, XX, +7[8]/46, XX[21] no   -   TOP* affected
12 46, XX[50] 92, XXXX[23]/46, XX[27] no   -   partus 33 weeks, livebirth, no congenital anomalies not affected
13 46, XY[4] 47, XY, +?18[2]/
46, XY[37]
yes   -   unknown affected
14 46, XX[8] 47, XX, +?20[2]/46, XX[7] yes   -   TOP* affected
Aberration in STC and LTC         
15 45, X[3]/46, XX[1] 45, X[1]/46, XX[8] yes   skin biopsy post partum 46, XX CPM III TOP* affected
16 45, X[1]/46, XY[2] 45, X[1]/46, XY[28] no   -   continued, livebirth, no congenital anomalies not affected
17 46, X, inv(Y)[5] 46, X, inv(Y)[9] no   inv(Y)pat   TOP* affected
18 47, XX, +mar[1]/
46, XX[3]
47, XX, +mar[1]/
46, XX[28]
no   parental karyotype normal   TOP affected*
Amniotic fluid sample         
19 - - yes 45, X[10]/
47, XXX[9]/
46, XX[2]
karyotype blood post partum 45, X[9]/
47, XXX[33]/46, XX[8], normal phenotype
  continued, livebirth, no congenital anomalies not affected
  1. * TOP: termination of pregnancy based on affected pregnancy (positive DNA analysis or metabolic testing); CPM: confined placental mosaicism